Subscribe free to our newsletters via your
. Nuclear Energy News .




EPIDEMICS
Revealed: Secret of HIV's natural born killers
by Staff Writers
Paris (AFP) June 10, 2012


Scientists on Sunday said they had found a key piece in the puzzle as to why a tiny minority of individuals infected with HIV have a natural ability to fight off the deadly AIDS virus.

In a study they said holds promise for an HIV vaccine, researchers from four countries reported the secret lies not in the number of infection-killing cells a person has, but in how well they work.

Only about one person in 300 has the ability to control the human immunodeficiency virus (HIV) without drugs, using a strain of "killer" cells called cytotoxic T lymphocyte (CTL) cells, previous research has found.

Taking that discovery further, scientists from the United States, Canada, Japan and Germany reported that the strain has molecules called receptors that are better able to identify HIV-infected white blood cells for attack.

Until now, it was well known that people with HIV "have tonnes of these killer cells," Bruce Walker, an infectious diseases expert at the Ragon Institute in Massachusetts, told AFP.

"We have been scratching our heads since then, asking how, with so many killer cells around, people are getting AIDS. It turns out there is a special quality that makes them (some cells) better at killing."

The study looked at 10 infected people, of whom five took antiretroviral drugs to keep HIV under control while five were so-called elite controllers who remained naturally healthy.

HIV kills a type of white blood cell called CD4, leaving people with AIDS wide open to other, opportunistic and potentially deadly infections.

"What we found was that the way the killer cells are able to see infected cells and engage them was different," said Walker.

"It is not just that you need a killer cell, what you need is a killer cell with a (T cell) receptor that is particularly good at recognising the infected cell. This gives us a way to understand what it is that makes a really good killer cell."

Walker said attempts at creating vaccines had so far failed because the T cell receptors they generated were not the efficient type.

But while the research has showed scientists how to find and measure the good cells, they still do not yet know how to generate them.

"The next step is to determine what it is about those receptors that is endowing them with that ability," said Walker.

"HIV has revealed another one of its secrets and that is how the body is able to effectively control the virus in certain individuals.

"Each secret that HIV reveals is putting us in a better position to ultimately make a vaccine to control the virus."

.


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola






Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle








EPIDEMICS
New study shows why swine flu virus develops drug resistance
Bristol UK (SPX) Jun 08, 2012
Computer chips of a type more commonly found in games consoles have been used by scientists at the University of Bristol to reveal how the flu virus resists anti-flu drugs such as Relenza and Tamiflu. Professor Adrian Mulholland and Dr Christopher Woods from Bristol's School of Chemistry, together with colleagues in Thailand, used graphics processing units (GPUs) to simulate the molecular ... read more


EPIDEMICS
Environmental benefit of biofuels is overestimated, new study claims

Steel-Strength Plastics That Are Clean And Green

Bigger refuges needed to delay pest resistance to biotech corn

Gasification may convert mesquite and juniper wood to a usable bioenergy

EPIDEMICS
Photovoltaic Cells Tap Underwater Solar Energy

New twist on old chemical process could boost energy efficiency

Solar cells for underwater use developed

Renewable energy costs falling: agency

EPIDEMICS
Change in air as Africa's biggest wind farm set for Kenya

Wind Powering An Island Economy

China Leads Growth in Global Wind Power Capacity

US slaps duties on Chinese wind towers

EPIDEMICS
TEPCO to buy 1 million tons LNG a year from Qatar

Nuclear and coal-fired electrical plants vulnerable to climate change

American Electric Power Pulls Billion Dollar Big Sandy Request

US and European energy supplies vulnerable to climate change

EPIDEMICS
Gazprom may pay Bulgaria's pipeline share

China to lower fuel prices

Bombs hit Iraq pipelines, exports unhurt: officials

Tennessee takes big step towards nuclear fusion power

EPIDEMICS
Tiny Planet-Finding Mirrors Borrow from Webb Telescope Playbook

Astronomers Probe 'Evaporating' Planet Around Nearby Star with Hobby-Eberly Telescope

Venus transit may boost hunt for other worlds

NSO To Use Venus Transit To Fine-Tune Search For Other Worlds

EPIDEMICS
U.S. braces for action in Persian Gulf

Taiwan probes 'stealth' boat's missing computer

US Navy Littoral Combat Ship Delivered Two Months Early

Future of fire-hit nuclear sub uncertain

EPIDEMICS
NASA's Mars rover zeroes in on August landing

Russia May Join Mars Orbiter Project in Nov. - ESA

Robotic Arm Gets to Work on Veins of Gypsum

Odyssey Orbiter Puts Itself into Standby Safe Mode




The content herein, unless otherwise known to be public domain, are Copyright 1995-2014 - Space Media Network. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement